Purity and Composition of Cannabis, Heroin and Ecstasy Samples Used in Bursa Region
Keywords:
Cannabis, heroin, ecstasy (MDMA), purity, BursaAbstract
Objective: The aims of this study were to determine the purity and composition of 21 cannabis, 55 heroin and 65 ecstasy samples seized by law enforcement agencies in Bursa region, and to discuss the probable risks of determined active substance levels and additives for humans using these drugs.
Method: The samples were analysed by gas chroma-tography/mass spectrometry (GC/MS) and infrared spectrometry (FTIR).
Results: The mean concentrations of tetrahidrocanna-binol (THC) in cannabis, diacetylmorphine in heroin samples and 3,4-methylenedioxymethamphetamine (MDMA) in ecstasy tablets were found to be 2.67 %, 41.51 % and 35.10 %, respectively. Griseofulvin, caffeine, and paracetamol derivates were found in heroin samples, while dexamphetamine, N-formilamphetamine, amphetamine, metamphetamine, caffeine, theophylline, quinine, yohimbine, methaqualone, barbital, phenobarbital, bromazepam, piracetam, cinnarizi-ne, artane, vanillin, lactose, dextrose, sorbitol, sucrose, calcium phosphate, sodium thiosulfate and face powder were found in ecstasy samples.
Conclusion: The purity of heroin and ecstasy samples were highly variable. THC levels in cannabis samples were within normal limits. THC amounts in cannabis may be a serious risk for user health only when cannabis is used in high amounts and with alcohol, whereas the active substance levels and some additives in heroin and ecstasy could be a direct serious risk factor for user health.
References
Smyth BP, O'Brien M. Research report: Children attending addiction treatment services in Dublin, 1990-1999. Europ Addict Res 2004;1:68-74.
Saferstein R. Criminalistics, an Introduction to Forensic Science. 7th Edn, New Jersey, Prentice Hall, 2001:228-255.
Evren C, Tamar D, Ogel K, Corapcioglu A, Cakmak D: Damar yolu ile eroin kullanımı ve ilişkili bazı davranış biçimleri. Klinik Psikiyatri Dergisi 2000;3:185-191.
Ögel K, Tamar D, Evren C, Çakmak D: İstanbul'da lise ögrencileri arasinda sigara, alkol ve madde kullanim yayginligi. Klinik Psikiyatri Dergisi 2000;3:242-245.
Emniyet Genel Müdürlüğü (EGM). Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı, 2003, 2002-2003 Yıllık Rapor.
Ögel K, Çorapçıoğlu A, Tot S, ve ark.Türkiye'de ortaöğretim gençliği arasında ekstazi kullanımı. Bağımlılık Dergisi 2003;4:67-71.
Emniyet Genel Müdürlüğü (EGM). Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı, 2002, 2001-2002 Yıllık Rapor.
Spruit IP. Monitoring synthetic drug markets, trends, and public health. Subst Use Misuse 2001;36(1-2):23-47.
Maher L, Swift W, Dawson M: Heroin purity and composition in Sydney, Australia. Drug Alcohol Rev 2001;20:439-448.
Wendel T, Rothchild R, Curtis R, et al. Heroin cut with morphine? An ethnographic-forensic chemistry case study. Addict Res Theory 2003;5:349-366.
Şahin Y. İdrar içerisindeki suistimal edilen maddelerden eroin, esrar ve kokainin izolasyon ve GC/MS tekniği ile tanımlanması. Yüksek Lisans Tezi, Ankara: Hacettepe Üniversitesi, Fen Bilimleri Enstitüsü, 1996.
Kayaalp O.Tıbbi Farmakoloji, Ankara: Hacettepe-Taş Kitapçılık, 2000:1004-1024.
Ramaekers JG, Berghaus G, Laar van M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004;73:109-119.
Bates MN, Blakey TA: Role of cannabis in motor vehicle crashes. Epidemiol Rev 1999;21: 222232.
Drummer OH, Gerostamoulos J, Batziris H, et al. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int 2003;8:154-162.
Hser Y, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotic addicts. Arc Gen Psychiatry 2001;58:503-508.
Quaglio G, Talamini G, Lechi A, et al. Study of 2708 heroin-related deaths in north-eastern Italy 1985-1998 to establish main causes of death. Addiction 2001;96:1127-1137.
Darke S, Hall W, Weatherburn D, Lind B. Fluctiations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999;54:154-161.
Risser D, Honigschnabl S, Stichenwirth M, et al. Drug-related emergencies and drug-related deaths in Vienna, 1195-1997. Drug Alcohol Depend 2001;61:307-313.
Coomber R. How often does the adulteration/ dilution of heroin actually occur? An analysis of 228 "street" heroin samples across the UK(1995-1996) and discussion of monitoring policy. Int J Drug Policy 1997; 8:178-186.
Man LH, Best D, Gossop M, et al. Relationship between prescribing and riskof opiate overdose among drug users in and out of maintanance treatment. Eur Addict Res 2004;10:35-40.
Schifano F, Di Furia L, Forza G, et al. MDMA ("ecstasy") comsuption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 1998;52: 85-90.
Baggott M, Heifets B, Jones RT, et al. Chemical analysis of Ecstasy pills. JAMA 2000;284:2190-2191.
Cole CJ, Bailey M, Sumnall HR, et al.The content of ecstasy tablets: implications for the study of their long-term effects. Addiction 2002;97:1531-1536.
Spruit IP. Ecstasy use and policy responses in the Netherlands. J Drug Issues 1999;29:653-678.
Cole JC, Sumnall HR. Altered states: the clinical effects of ecstasy. Pharmacol Ther 2003;98:35-58.
Schmued LC. Demonstration of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 2003;974:127-133.
Greene SL, Dargan PI, O'Connor N, et al. Multiple toxicity from 3,4-metilendioksimetamfetamine ("Ecstasy"). Am J Emerg Med 2003;21:121-124.
Schifano F, Oyefeso A, Corkery J, et al. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. Hum Psychopharmacol Clin Exp 2003;18:519-524.
Kaa E, Bent K. Imprities, adulterants and diluents illicit heroin in Denmark. Forensic Sci Int 1986;77: 347-348.
Coomber R. The adulteration of illicit drugs with dangerous substances the discovery of a "myth". Contemp Drug Probl 1997; 24:239-271.
Furst RT. The re-engineering of heroin: an emerging heroin "cutting" trend in New York City. Addict Res 2000;8: 357-379.
Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons, London: Pharmaceutical Pres, 2004, 37-53.
Chemical Analysis Catalog (GC-MS). Chemical analysis consumables and accessories, Hewlett Packard, 1998-1999, 1999, California, USA/ Waldbronn, Germany.
Instruction Manuel FTIR-8400/8900, Command Reference, 1998, Kyoto, Japan.
Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend 2003;70:275-286.
Darke S, Hall W. Heroin overdose: Research and evidence-based intervention. J Urban Health 2003;80:189-200.
Stewart D, Gossop M, Marsden J. Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS). J Subs Abuse Treat 2002; 22: 1-9.
Seymour A, Oliver JS, Black M. Drug-related deaths among recently released prisoners in the Strathclyde rigion of Scotland. J Forensic Sci 2000;45:649-654.
Neale J. Suicidal intent in non-fatal illicit drug overdose. Addiction 2000;95:85-93.
Fundaro C, Martino AM, Chiarotti M, et al. Cannabis acute intoxication. Rivista Italiana Di Pediatria/Italian J Ped 1995;21(3):309-311.
Nerkis S. Bursa ve Çevresinde Kullanılan uyuşturucu maddelerden Eroin, Esrar ve Ekstazi Tabletlerinin Etkin Madde Miktarlarının Belirlenmesi ve Biyolojik Materyalde Araştırılması. Uludağ Üniversitesi, Sağlik Bilimleri Enstitüsü (MSc thesis), 2004, Bursa.
King LA. Drug content of powders and other illicit preparations in the UK. Forensic Sci Int 1997;85:13 5-147.
Domestic Strategic Intelligence Unit. United States Drug Enforcement Administration, Drug trafficking in the United States,1996, Alexandria.
Domestic Strategic Intelligence Unit. United States Drug Enforcement Administration, Drug trafficking in the United States, 2001, Alexandria.
National Drug Intelligence Center. Heroin distribution in three cities, National Drug Intelligence Center, 2000a, Johnstown.
National Drug Intelligence Center. Interagency domestic heroin threat assessment, National Drug Intelligence Center, 2000b, Johnstown.
Darke S, Topp L, Kaye S, Hall W. Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction 2002;97:179-186.
Hamilton RJ, Perrone J, Hoffman RA. Descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. J Clin Toxicol 2000;38: 597-608.
Kaa E. Impruties, adulterants and diluents of illicit heroin. Changes during a 12-year period. Forensic Sci Int 1994;64:171-179.
Katzung BG. Temel ve Klinik Farmakoloji. Çeviren: Özüner Z, Istanbul: Barıs Kitabevi, 1995:634-652.
Warner-Smith M, Darke S. Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction 2001;95:941-948.
Garfield J, Drucker E. Fatal overdose trends in major US cities 1990-1997. Addict Res Theory 2001;9:425-436.
Goldberger BA, Cone EJ, Grant TM, et al. Disposition of heroin and its metabolites in heroin related deaths. J Anal Toxicol 1994;18:22-28.
Risser D, Uhl A, Stichenwirth M, et al. Quality of heroin and heroin-related deaths from 1987 to 1995 in Vienna, Austria. Addiction 2000;5:375-382.
Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav 2001;26:453-460.
Topp L, Breen C, Kaye S, Darke S. Adapting the Illicit Drug Reporting System (IDRS) to examine the feasibility of monitoring trends in the markets for party drugs. Drug Alcohol Depend 2004;73:189-197.
Kaa E. Street drugs in Denmark. J Forensic Sci 1991;36:866-879.
Parrott AC. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels and the changing perceptions of purity. Is ecstasy MDMA?. Psychopharmacology 2004;73:234-242.
Moffat AC, Jackson JV, Moss MS, Widdop B. Clarke's isolation and identification of drugs, London: Pharmaceutical Press, 1986.
Gökçe E. Ekstazi tabletlerinin ilişkilendirilmesi ve kaynaklarının belirlenmesi.Yüksek Lisans Tezi, Ankara: Gazi Üniversitesi, Fen Bilimleri Enstitusu, 2002.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Dependence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
...